Two Sigma Advisers LP Has $64.25 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Two Sigma Advisers LP increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4,824.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 123,100 shares of the medical equipment provider’s stock after purchasing an additional 120,600 shares during the period. Two Sigma Advisers LP’s holdings in Intuitive Surgical were worth $64,253,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Finally, Truist Financial Corp lifted its position in shares of Intuitive Surgical by 3.0% in the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock worth $129,494,000 after purchasing an additional 7,298 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Evercore ISI lowered their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 23rd. Finally, UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $561.63 on Tuesday. The stock’s 50-day moving average is $506.50 and its 200-day moving average is $537.23. The company has a market cap of $201.30 billion, a P/E ratio of 87.62, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52-week low of $395.60 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the firm posted $1.50 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. The trade was a 63.13% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock valued at $16,865,621 in the last ninety days. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.